Samsung Biologics Public offering
삼성바이오로직스 · Upcoming
Offer price₩1,174,000Final terms filed
Shares offered2,270,000
Offering size₩2.66tn
SubscriptionMon Nov 9
Samsung Biologics (삼성바이오로직스) public offering subscription runs Mon Nov 9 to Tue Nov 10. The offer price is ₩1,174,000 for 2,270,000 shares, about ₩2.66tn in total. Underwriters: Shinhan Securities, NH Investment & Securities, Korea Investment & Securities, KB Securities. Payment and refund date: Tue Nov 17.
Underwriters
| Role | Broker | Shares | Amount |
|---|---|---|---|
| Lead | Shinhan Securities | 681,000 | ₩799bn |
| Lead | NH Investment & Securities | 681,000 | ₩799bn |
| Lead | Korea Investment & Securities | 454,000 | ₩533bn |
| Lead | KB Securities | 454,000 | ₩533bn |
Samsung Biologics public offering FAQ
- When is the Samsung Biologics public offering subscription?
- Mon Nov 9 to Tue Nov 10 (Korea time). Refunds and payment are on Tue Nov 17.
- What is the Samsung Biologics public offering price?
- ₩1,174,000 per share.
From the DART registration statement (equity securities). Book-building and subscription results are added once the final terms filing and issuance result report are published; listing dates are not included. Not investment advice.